{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:39:29Z","timestamp":1792395569370,"version":"4.4.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbagen.2026.130989","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:56Z","timestamp":1787067656000},"page":"130989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging molecular mechanism of neuroinflammation in Parkinson's disease: A JAK\/STAT and TGF\u03b2\/SMAD signaling crosstalk"],"prefix":"10.1016","volume":"1870","author":[{"given":"Kaustav","family":"Purkayastha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhideep","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupom","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130989_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbagen.2026.130989_bb0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/0109298665391103250825102319","article-title":"Precision enzyme: targeted drug discovery in neurodegenerative disorders","volume":"32","author":"Paul","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbagen.2026.130989_bb0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1073858421991066","article-title":"Neuroinflammation in Parkinson\u2019s disease: triggers, mechanisms, and immunotherapies","volume":"28","author":"Wang","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbagen.2026.130989_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-024-03043-5","article-title":"Parkinson\u2019s disease-derived \u03b1-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype","volume":"21","author":"Yildirim-Balatan","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbagen.2026.130989_bb0030","doi-asserted-by":"crossref","DOI":"10.2174\/0109298665333333240909104354","article-title":"Investigating in silico and in vitro therapeutic potential of diosmetin as the anti-Parkinson agent","volume":"31","author":"Varshney","year":"2024","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbagen.2026.130989_bb0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/antiox12040955","article-title":"Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products","volume":"12","author":"Chakrabarti","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbagen.2026.130989_bb0040","doi-asserted-by":"crossref","DOI":"10.1042\/AN20120066","article-title":"Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity","volume":"5","author":"Sanchez-Guajardo","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.bbagen.2026.130989_bb0045","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429275495231215054024","article-title":"Depression-like behavior induced by repeated administration of dexamethasone to lipopolysaccharide-inflamed mice","volume":"17","author":"Shibagaki","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0050","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/09727531211070532","article-title":"Role of JAK\/STAT in the neuroinflammation and its association with neurological disorders","volume":"28","author":"Jain","year":"2021","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114760","article-title":"Targeting the JAK-STAT pathway in autoimmune diseases and cancers: a focus on molecular mechanisms and therapeutic potential","volume":"193","author":"Tzeng","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0065","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cells10061382","article-title":"TGF-\u03b2\/Smad signalling in neurogenesis: implications for neuropsychiatric diseases","volume":"10","author":"Hiew","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2026.130989_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","article-title":"The potential role of neuroinflammation and transcription factors in Parkinson disease","volume":"19","author":"Tiwari","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655819","article-title":"Genetic imaging of neuroinflammation in Parkinson\u2019s disease: recent advancements","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1101\/gad.14.2.187","article-title":"A mechanism of suppression of TGF\u2013\u03b2\/SMAD signaling by NF-\u03baB\/RelA","volume":"14","author":"Bitzer","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagen.2026.130989_bb0085","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.24976\/Discov.Med.202436186.129","article-title":"Effects of IL-6R expression on IL-6\/STAT3\/HIF-1\u03b1 signaling pathway in a mouse model of Parkinson\u2019s disease with type 2 diabetes co-morbidity","volume":"36","author":"Hu","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.bbagen.2026.130989_bb0090","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","article-title":"Deficiency in neuronal TGF-\u03b2 signaling leads to nigrostriatal degeneration and activation of TGF-\u03b2 signaling protects against MPTP neurotoxicity in mice","volume":"37","author":"Tesseur","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cimb47010008","article-title":"Mechanisms and emerging regulators of neuroinflammation: exploring new therapeutic strategies for neurological disorders","volume":"47","author":"Kim","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3389\/fneur.2018.00860","article-title":"Outside in: unraveling the role of neuroinflammation in the progression of Parkinson\u2019s disease","volume":"9","author":"Troncoso-Escudero","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbagen.2026.130989_bb0115","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson\u2019s disease\u2014from neurodegeneration to therapeutic opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2026.130989_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbagen.2026.130989_bb0125","article-title":"A detailed review of molecular pathways and mechanisms responsible for the development and aggravation of neuropathy and nephropathy in diabetes","volume":"17","author":"Chandra","year":"2023","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0130","doi-asserted-by":"crossref","DOI":"10.1042\/NS20220063","article-title":"Cytokine activity in Parkinson\u2019s disease","volume":"7","author":"Dzamko","year":"2023","journal-title":"Neuronal Signal."},{"key":"10.1016\/j.bbagen.2026.130989_bb0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2026.130989_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.636139","article-title":"Genetic defects and pro-inflammatory cytokines in Parkinson\u2019s disease","volume":"12","author":"Magnusen","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0150","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/antiox12071411","article-title":"Neuroinflammation and mitochondrial dysfunction in Parkinson\u2019s disease: connecting neuroimaging with pathophysiology","volume":"12","author":"Pizarro-Galleguillos","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbagen.2026.130989_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbi.2024.08.015","article-title":"Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines","volume":"122","author":"Sigutova","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbagen.2026.130989_bb0160","doi-asserted-by":"crossref","first-page":"45663","DOI":"10.1021\/acsomega.4c06546","article-title":"The impact of the blood\u2013brain barrier and its dysfunction in Parkinson\u2019s disease: contributions to pathogenesis and progression","volume":"9","author":"Iqbal","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbagen.2026.130989_bb0165","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2026.130989_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","article-title":"Neuroinflammation in parkinson\u2019s disease and its treatment opportunities","volume":"39","author":"\u00c7\u0131nar","year":"2022","journal-title":"Balkan Med. J."},{"key":"10.1016\/j.bbagen.2026.130989_bb0175","doi-asserted-by":"crossref","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbagen.2026.130989_bb0185","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cells12192336","article-title":"Astrocytes in Parkinson\u2019s disease: from role to possible intervention","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbagen.2026.130989_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.666737","article-title":"The pathogenesis of Parkinson\u2019s disease: a complex interplay between astrocytes, microglia, and T lymphocytes?","volume":"12","author":"MacMahon Copas","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0195","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00415-022-11491-3","article-title":"Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"270","author":"Soraci","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0200","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1571074","article-title":"Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson\u2019s disease","volume":"16","author":"Thome","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0210","article-title":"Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson\u2019s disease","volume":"21","author":"Diaz","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbagen.2026.130989_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1682006","article-title":"Peripheral\u2013central immune interactions in Parkinson\u2019s disease: insights into innate and adaptive immunity","volume":"18","author":"Tumpa","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0220","article-title":"The gut-brain axis and its relation to Parkinson\u2019s disease: a review","volume":"13","author":"Klann","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0225","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11011-021-00808-2","article-title":"Gut brain axis: an insight into microbiota role in Parkinson\u2019s disease","volume":"36","author":"Moustafa","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbagen.2026.130989_bb0230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/07853890.2021.1890330","article-title":"The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance","volume":"53","author":"Menozzi","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbagen.2026.130989_bb0235","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4103\/1673-5374.373673","article-title":"Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson\u2019s disease","volume":"18","author":"Claudino Dos Santos","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbagen.2026.130989_bb0240","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbagen.2026.130989_bb0245","first-page":"1","article-title":"Immune responses in Parkinson\u2019s disease: interplay between central and peripheral immune systems","volume":"2014","author":"Su","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbagen.2026.130989_bb0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood\u2013brain barrier permeability in Parkinson\u2019s disease","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbagen.2026.130989_bb0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arr.2017.10.002","article-title":"Chronic inflammation - inflammaging - in the ageing cochlea: a novel target for future presbycusis therapy","volume":"40","author":"Watson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbagen.2026.130989_bb0260","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1189\/jlb.0208108","article-title":"Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system","volume":"84","author":"Dilger","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","article-title":"Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease","volume":"76","author":"Coskun","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0270","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.phrs.2016.05.015","article-title":"Perspective: targeting the JAK\/STAT pathway to fight age-related dysfunction","volume":"111","author":"Xu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0280","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","article-title":"Inhibition of the JAK\/STAT pathway protects against \u03b1-synuclein-induced neuroinflammation and dopaminergic neurodegeneration","volume":"36","author":"Qin","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0290","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114451","article-title":"Interference of layered double hydroxide nanoparticles with pathways for biomedical applications","volume":"188","author":"Jing","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbagen.2026.130989_bb0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbagen.2026.130989_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108402","article-title":"Selective JAK1 inhibitors for the treatment of inflammatory bowel disease","volume":"245","author":"Nielsen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0315","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/1535-7163.MCT-10-0502","article-title":"JAK1 activates STAT3 activity in non-small\u2013cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling","volume":"10","author":"Song","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5603\/FHC.a2022.0021","article-title":"Activation of the JAK1\/STAT1 signaling pathway is associated with peroxiredoxin 6 expression levels in human epididymis epithelial cells","volume":"60","author":"Shi","year":"2022","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0325","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab024","article-title":"JAK1: number one in the family; number one in inflammation?","volume":"60","author":"Spinelli","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbagen.2026.130989_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0335","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00109-010-0628-z","article-title":"JAK2 inhibition prevents innate immune responses and rescues animals from sepsis","volume":"88","author":"Pe\u00f1a","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbagen.2026.130989_bb0340","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cyto.2015.11.011","article-title":"The good and the bad faces of STAT1 in solid tumours","volume":"89","author":"Meissl","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.bbagen.2026.130989_bb0345","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.4049\/jimmunol.1001343","article-title":"STAT1-activating cytokines limit Th17 responses through both T-bet\u2013dependent and\u2013independent mechanisms","volume":"185","author":"Villarino","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2018.12.004","article-title":"Targeting STATs in neuroinflammation: the road less traveled!","volume":"141","author":"Nabavi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3644","article-title":"STAT3 is critical to promote inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"14","author":"Miyamoto","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0360","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0365","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbagen.2026.130989_bb0370","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1 and TNF -initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"23","author":"Mori","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0375","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/svn-2021-001028","article-title":"Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage","volume":"7","author":"Zheng","year":"2022","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0380","doi-asserted-by":"crossref","first-page":"100","DOI":"10.31138\/mjr.31.1.100","article-title":"Basic mechanisms of JAK inhibition","volume":"31","author":"Lin","year":"2020","journal-title":"Mediterr. J. Rheumatol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0385","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/pathogens14040324","article-title":"The dual-edged sword: risks and benefits of JAK inhibitors in infections","volume":"14","author":"Jarneborn","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.bbagen.2026.130989_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.855776","article-title":"Pre-clinical studies identifying molecular pathways of neuroinflammation in Parkinson\u2019s disease: a systematic review","volume":"14","author":"Fathi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0395","series-title":"Jak-Stat Signaling\u00a0: From Basics to Disease","first-page":"353","article-title":"Crosstalk with the Jak-STAT pathway in inflammation","author":"Ivashkiv","year":"2012"},{"key":"10.1016\/j.bbagen.2026.130989_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116747","article-title":"Neuroprotective effects of increasing levels of HSP70 against neuroinflammation in Parkinson\u2019s disease model by inhibition of NF-\u03baB and STAT3","volume":"234","author":"Li","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0405","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/jisp.jisp_301_16","article-title":"A critique on nuclear factor-kappa B and signal transducer and activator of transcription 3: the key transcription factors in periodontal pathogenesis","volume":"21","author":"Ambili","year":"2017","journal-title":"J. Indian Soc. Periodontol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0410","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/pr2030570","article-title":"Mathematical modeling and analysis of crosstalk between MAPK pathway and Smad-dependent TGF-\u03b2 signal transduction","volume":"2","author":"Liu","year":"2014","journal-title":"Processes"},{"key":"10.1016\/j.bbagen.2026.130989_bb0415","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","article-title":"Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-\u03b2: implications for carcinogenesis","volume":"24","author":"Javelaud","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagen.2026.130989_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2008.302","article-title":"Signaling cross-talk between TGF-\u03b2\/BMP and other pathways","volume":"19","author":"Guo","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2026.130989_bb0430","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10787-021-00800-3","article-title":"Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways","volume":"29","author":"Ibrahim","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbagen.2026.130989_bb0435","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/biom10030487","article-title":"TGF-\u03b2 Signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbagen.2026.130989_bb0440","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2026.130989_bb0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0450","doi-asserted-by":"crossref","first-page":"78","DOI":"10.18632\/oncotarget.1569","article-title":"Perspectives of TGF-\u03b2 inhibition in pancreatic and hepatocellular carcinomas","volume":"5","author":"Neuzillet","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2026.130989_bb0455","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022244","article-title":"TGF-\u03b2 family signaling in neural and neuronal differentiation, development, and function","volume":"9","author":"Meyers","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0460","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation","volume":"7","author":"Lan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0465","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12032-025-02667-8","article-title":"Targeting TGF-\u03b2: a promising strategy for cancer therapy","volume":"42","author":"Himani","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0470","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/diagnostics13172769","article-title":"SMAD proteins in TGF-\u03b2 signalling pathway in cancer: regulatory mechanisms and clinical applications","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbagen.2026.130989_bb0475","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2026.130989_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.593310","article-title":"The Smad dependent TGF-\u03b2 and BMP signaling pathway in bone remodeling and therapies","volume":"8","author":"Zou","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0485","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1046\/j.1523-1755.2000.07708.x","article-title":"Smad proteins and transforming growth factor-\u03b2 signaling","volume":"58","author":"Schiffer","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbagen.2026.130989_bb0490","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/10409238.2020.1828260","article-title":"Current perspectives on inhibitory SMAD7 in health and disease","volume":"55","author":"de Ceuninck van Capelle","year":"2020","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105303","article-title":"TGF-\u03b21\/SMADs signaling involved in alleviating inflammation induced by nanoparticulate titanium dioxide in BV2 cells","volume":"80","author":"Huang","year":"2022","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bbagen.2026.130989_bb0500","doi-asserted-by":"crossref","first-page":"107256","DOI":"10.1016\/j.jbc.2024.107256","article-title":"Receptor-activated transcription factors and beyond: multiple modes of Smad2\/3-dependent transmission of TGF-\u03b2 signaling","volume":"300","author":"Miyazawa","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130989_bb0505","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/nar\/29.3.732","article-title":"Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins","volume":"29","author":"Quinn","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0510","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","article-title":"Cellular and molecular basis for the regulation of inflammation by TGF-\u03b2","volume":"147","author":"Yoshimura","year":"2010","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbagen.2026.130989_bb0515","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1093\/emboj\/19.19.5178","article-title":"Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-\u03b2","volume":"19","author":"Feng","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2026.130989_bb0520","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3390\/biomedicines12112468","article-title":"TGF-\u03b2 signaling in microglia: a key regulator of development, homeostasis and reactivity","volume":"12","author":"Li","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbagen.2026.130989_bb0525","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","article-title":"Immune signaling in neurodegeneration","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbagen.2026.130989_bb0530","first-page":"1","article-title":"SMAD7: riding on fibrosis-limiting routes and beyond","author":"Martin","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbagen.2026.130989_bb0535","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00109-021-02083-1","article-title":"Expression and function of Smad7 in autoimmune and inflammatory diseases","volume":"99","author":"Hu","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbagen.2026.130989_bb0540","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmp018","article-title":"Regulation of TGF-\u03b2 signaling by Smad7","volume":"41","author":"Yan","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.bbagen.2026.130989_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20101827","article-title":"Smad7: not only a regulator, but also a cross-talk mediator of TGF-\u03b2 signalling","volume":"434","author":"Yan","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2026.130989_bb0550","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","article-title":"The MAD-related protein Smad7 associates with the TGF\u03b2 receptor and functions as an antagonist of TGF\u03b2 signaling","volume":"89","author":"Hayashi","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2026.130989_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.crimmu.2023.100055","article-title":"Smad7 as a positive regulator of intestinal inflammatory diseases","volume":"4","author":"Monteleone","year":"2023","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0560","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1128\/MCB.01636-06","article-title":"Smad7 antagonizes transforming growth factor \u03b2 signaling in the nucleus by interfering with functional Smad-DNA complex formation","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0565","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12974-023-02849-z","article-title":"Smad7 in the hippocampus contributes to memory impairment in aged mice after anesthesia and surgery","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbagen.2026.130989_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-1-44","article-title":"Unraveling the biological functions of Smad7 with mouse models","volume":"1","author":"Zhu","year":"2011","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0575","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI12821","article-title":"Blocking Smad7 restores TGF-\u03b21 signaling in chronic inflammatory bowel disease","volume":"108","author":"Monteleone","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2026.130989_bb0580","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/onc.2012.260","article-title":"Targeting Stat3 and Smad7 to restore TGF-\u03b2 cytostatic regulation of tumor cells in vitro and in vivo","volume":"32","author":"Luwor","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagen.2026.130989_bb0585","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/abbs\/gmx118","article-title":"Smad3\u2013STAT3 crosstalk in pathophysiological contexts","volume":"50","author":"Itoh","year":"2018","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.bbagen.2026.130989_bb0590","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.190.Supp.48.14","article-title":"Leptin antagonist reduces STAT1\/3 activation, lessens Smad7 expression, restores TGF-\u03b21 signaling and induces regulatory T cells (Tregs) to ameliorate chronic colitis (P4208)","volume":"190","author":"Singh","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0600","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1101\/gad.14.2.187","article-title":"A mechanism of suppression of TGF-beta\/SMAD signaling by NF-kappa B\/RelA","volume":"14","author":"Bitzer","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbagen.2026.130989_bb0605","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2026.130989_bb0610","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1158\/1078-0432.CCR-21-0935","article-title":"Integrated human and murine clinical study establishes clinical efficacy of ruxolitinib in chronic myelomonocytic leukemia","volume":"27","author":"Hunter","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130989_bb0615","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","article-title":"Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus","volume":"12","author":"Hasni","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagen.2026.130989_bb0620","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","article-title":"Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study","volume":"80","author":"Deodhar","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbagen.2026.130989_bb0625","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2026.130989_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1110765","article-title":"JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens","volume":"11","author":"Hu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0635","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/vde.12186","article-title":"A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs","volume":"26","author":"Little","year":"2015","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0640","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cas.12683","article-title":"Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed\/refractory hematological malignancies","volume":"106","author":"Ogura","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbagen.2026.130989_bb0645","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055718","volume":"12","author":"Nishina","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbagen.2026.130989_bb0650","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-014-2480-2","article-title":"Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors","volume":"74","author":"Bendell","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0655","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(22)01212-0","article-title":"Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Deodhar","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2026.130989_bb0660","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1111\/bcp.15239","article-title":"Exposure-response relationships for the efficacy and safety of filgotinib and its metabolite GS-829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies","volume":"88","author":"Meng","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0665","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.18207","article-title":"Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2) in patients with myelofibrosis and low pretreatment platelet counts","volume":"198","author":"Harrison","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0670","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-021-02590-z","article-title":"Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis","volume":"23","author":"Tanaka","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbagen.2026.130989_bb0675","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41375-022-01637-7","article-title":"Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis","volume":"36","author":"Mesa","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bbagen.2026.130989_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1196413","article-title":"Alzheimer\u2019s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?","volume":"14","author":"Melchiorri","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0695","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2026.130989_bb0700","article-title":"Echinacoside protects dopaminergic neurons through regulating IL-6\/JAK2\/STAT3 pathway in Parkinson\u2019s disease model","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0705","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.imlet.2020.10.004","article-title":"STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation","volume":"228","author":"Millot","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbagen.2026.130989_bb0710","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-024-03210-8","article-title":"Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson\u2019s disease","volume":"21","author":"Hong","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbagen.2026.130989_bb0715","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its effects on human health","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods"},{"key":"10.1016\/j.bbagen.2026.130989_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115236","article-title":"JAK-STAT signaling pathway in non-infectious uveitis","volume":"204","author":"Su","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130989_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114688","article-title":"TTI-101: a competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain","volume":"192","author":"Kasembeli","year":"2021","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:41:46Z","timestamp":1792392106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":142,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304416526000899"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130989","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging molecular mechanism of neuroinflammation in Parkinson's disease: A JAK\/STAT and TGF\u03b2\/SMAD signaling crosstalk","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130989"}}